Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation
- 1 September 1998
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 54 (3), 938-944
- https://doi.org/10.1046/j.1523-1755.1998.00042.x
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Neoral vs sandimmun: Interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipientsTransplantation Proceedings, 1997
- EVIDENCE FOR EARLIER STABILIZATION OF CYCLOSPORINE PHARMACOKINETICS IN DE NOVO RENAL TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATIONTransplantation, 1996
- THE SAFETY AND TOLERABILITY OF CYCLOSPORINE EMULSION VERSUS CYCLOSPORINE IN A RANDOMIZED, DOUBLE-BLIND COMPARISON IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1Transplantation, 1996
- THE PHARMACOKINETICS OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN PRIMARY RENAL ALLOGRAFT RECIPIENTS1Transplantation, 1996
- CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION—A MULTICENTER INVESTIGATION IN KIDNEY TRANSPLANT PATIENTSTransplantation, 1994
- Reduced Inter- and Intraindividual Variability in Cyclosporine Pharmacokinetics from a Microemulsion FormulationJournal of Pharmaceutical Sciences, 1994
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993
- LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation.British Journal of Clinical Pharmacology, 1992
- Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood.Clinical Chemistry, 1988